IMNR can't agree with partner
By Laura Erickson
Contributing Editor

The Immune Response Corp. and Rhone-Poulenc Rorer are putting the future management of clinical trials of their AIDS vaccine into the hands of arbitrators. IMNR and Rhone-Poulenc filed separate arbitration motions before the American Arbitration Association in St. Louis to decide their differences with respect to the management of additional clinical trials and the regulatory process.